SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-021971
Filing Date
2022-08-11
Accepted
2022-08-11 08:00:50
Documents
62
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 930535
2 ex31-1.htm EX-31.1 17504
3 ex31-2.htm EX-31.2 17466
4 ex32-1.htm EX-32.1 9759
  Complete submission text file 0001493152-22-021971.txt   5241815

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE ghsi-20220630.xsd EX-101.SCH 44535
6 XBRL CALCULATION FILE ghsi-20220630_cal.xml EX-101.CAL 52636
7 XBRL DEFINITION FILE ghsi-20220630_def.xml EX-101.DEF 177428
8 XBRL LABEL FILE ghsi-20220630_lab.xml EX-101.LAB 396768
9 XBRL PRESENTATION FILE ghsi-20220630_pre.xml EX-101.PRE 282288
56 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 793130
Mailing Address 2925 RICHMOND AVENUE SUITE 1200 HOUSTON TX 77098
Business Address 2925 RICHMOND AVENUE SUITE 1200 HOUSTON TX 77098 (800) 873-5141
Guardion Health Sciences, Inc. (Filer) CIK: 0001642375 (see all company filings)

IRS No.: 474428421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38861 | Film No.: 221153752
SIC: 2834 Pharmaceutical Preparations